HCA Healthcare Target Price

See HCA Healthcare's analyst price targets ($470) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$400.73

Average Target Price

$465.23

16.1% upside

26 analysts in the last 4 months

High: $579 | Low: $369

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-28	Goldman Sachs	$485	21% upside
2026-07-27	Robert W. Baird	$393	1.9% downside
2026-07-27	Deutsche Bank	$476	18.8% upside
2026-07-27	Morgan Stanley	$380	5.2% downside
2026-07-27	OppenheimerMichael Wiederhorn	$485	21% upside
2026-07-27	Barclays	$387	3.4% downside
2026-07-27	UBS	$579	44.5% upside
2026-07-27	KeyBanc	$435	8.6% upside
2026-07-20	Wells FargoStephen Baxter	$369	7.9% downside
2026-07-16	Barclays	$402	0.3% upside
2026-07-15	RBC Capital	$435	8.6% upside
2026-07-14	Jefferies	$450	12.3% upside
2026-07-13	Wells Fargo	$428	6.8% upside
2026-07-08	Barclays	$427	6.6% upside
2026-07-07	Cantor Fitzgerald	$525	31% upside
2026-07-07	Raymond JamesSarah James	$528	31.8% upside
2026-06-04	Truist Financial	$413	3.1% upside
2026-06-04	Bernstein	$413	3.1% upside
2026-04-27	KeyBanc	$510	27.3% upside
2026-04-27	Stephens	$530	32.3% upside
2026-04-27	Barclays	$496	23.8% upside
2026-04-27	Wells Fargo	$436	8.8% upside
2026-04-27	RBC Capital	$534	33.3% upside
2026-04-27	Oppenheimer	$520	29.8% upside
2026-04-27	Truist Financial	$535	33.5% upside
2026-04-24	Jefferies	$525	31% upside
2026-02-23	UBS	$635	58.5% upside
2026-02-09	Bernstein	$541	35% upside
2026-02-02	Mizuho Securities	$540	34.8% upside
2026-01-30	Wells Fargo	$481	20% upside
2026-01-28	UBS	$598	49.2% upside
2026-01-28	BarclaysAndrew Mok	$551	37.5% upside
2026-01-28	KeyBanc	$503	25.5% upside
2026-01-28	UBS	$588	46.7% upside
2026-01-28	Oppenheimer	$540	34.8% upside
2026-01-28	RBC Capital	$555	38.5% upside
2026-01-28	KeyBanc	$550	37.2% upside
2026-01-22	KeyBanc	$500	24.8% upside
2026-01-07	Wells FargoStephen Baxter	$452	12.8% upside
2026-01-06	Bernstein	$503	25.5% upside
2025-12-18	Mizuho Securities	$520	29.8% upside
2025-10-27	Oppenheimer	$500	24.8% upside
2025-10-27	Raymond JamesSarah James	$525	31% upside
2025-10-27	Goldman SachsScott Fidel	$520	29.8% upside
2025-10-27	Morgan Stanley	$425	6.1% upside
2025-10-27	UBS	$525	31% upside
2025-10-27	Barclays	$494	23.3% upside
2025-10-27	RBC CapitalBen Hendrix	$482	20.3% upside
2025-10-27	StephensRaj Kumar	$500	24.8% upside
2025-10-27	Truist Financial	$495	23.5% upside

HCA Healthcare (HCA) FAQ

HCA Healthcare's target price stands at $470. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $470 for HCA implies 16.1% upside versus today's price ($400.73). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how HCA Healthcare's target price evolved across reporting periods, while the comparison chart places HCA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. HCA Healthcare's reading of $470 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.